A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

Clinical trial NCT06747936 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06747936
Sponsor: Addpharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia

Start date: 2025-02-01
Primary completion: 2025-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.